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Abstract
Background:  The normal physiology of the gastrointestinal tract has been only cursorily
examined. Consequently, the pathophysiology of disturbances of the gastrointestinal functions is
poorly known. Recurrent vomiting is one of many functional conditions for which it is difficult to
find an explanation and to treat. In the following a case is described of a patient presenting with
recurrent vomiting episodes, whose condition improved spontaneously during pregnancy and
breast feeding.
Case presentation: A woman with recurrent vomiting episodes over several years was examined
by esophagogastroduodenoscopy. This showed a non-peristaltic ventricle. Treatment with the
procinetic drug cisapride (Prepulsid®) improved the peristalsis and reduced the symptoms. During
pregnancy and breast feeding, she was free of symptoms, in spite of having discontinued her
medication with cisapride (Prepulsid®).
Conclusion: The fact that the patient improved during pregnancy and breast feeding, would seem
to indicate the involvement of factors in the physiology of pregnancy and breast feeding that are of
importance for gastric motility. This deserves further investigation.
Background
The normal motor function of the gut is controlled by the
sympathetic and parasympathetic nervous system in addi-
tion to the enteric nervous system, interstitial cells of Cajal
(ICCs) and smooth muscle cells. Severe gastrointestinal
dysmotility, including gastroparesis, can develop as a
result of the abnormal function of any of these systems
including their associated neurotransmitters [1]. The
pathogenesis may be immune-mediated, as in post-infec-
tious gastroparesis [2], or may be due to defects in the
ICCs, autonomic nervous system and smooth muscle, as
in diabetic gastroparesis [3]. One third of all cases of gas-
troparesis are still regarded as idiopathic [4]. Several hor-
mones and neurotransmitters have been suggested to be
involved in this condition [5]. In clinical practice, I have
noticed that some patients with severe gastrointestinal
motility problems have improved during pregnancy and
breast feeding.
In the following, I describe a woman with recurrent vom-
iting and reduced gastric motility, who was completely
free of problems during pregnancy and breast feeding. A
hypothesis could be raised on this finding, namely, that
peptides and/or neurotransmitters appearing in altered
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concentrations during these conditions are involved in
the physiology and pathophysiology of the gastrointesti-
nal tract.
Case presentation
A previously healthy woman, born in 1975, with no
heredity for abdominal diseases, started to have attacks of
vomiting during her teenage period. Eating late in the
evening, caused her to wake up a few hours later with vio-
lent attacks of vomiting. To avoid vomiting, she had to
avoid these situations and had to stay awake many hours
after the last meal of the day. After some years she sought
medical help for this problem. An esophagogastroduode-
noscopy revealed an open cardia and a strikingly atonic,
non-peristaltic ventricle. This gave rise to the suspicion of
a defective emptying of the ventricle as a cause of the vom-
iting. The results of a histological examination of mucosal
biopsies from the ventricle and duodenum were normal.
Physical examination, including X-ray examination of
heart and lungs, showed no abnormality. Routine blood
samples were all within the normal range. She was not
using any drugs. Thus, no etiology of the impaired motil-
ity could be identified.
The patient was treated with the procinetic drug cisapride
(Prepulsid®). This drug improved her symptoms with
reduced vomiting, and she was able to eat in the evening.
Another esophagogastroduodenoscopy, done in the
course of the treatment with cisapride, showed an
improved, normalized peristalsis in the ventricle. After a
few years she became pregnant. She had stopped the med-
ication with cisapride when planning the pregnancy. A
light nausea was present during the first three months of
pregnancy, but there was no vomiting. Thus, in spite of
discontinuing the drug treatment during this period, she
had no vomiting episodes. This situation continued dur-
ing breast feeding, which lasted about 7 months. How-
ever, three to four weeks after the breast feeding was
terminated, her attacks of vomiting resumed, and cis-
apride (Prepulsid®) had to be reintroduced. When she was
expecting her second child, the same sequence of events
recurred. During pregnancy and breast feeding, which this
time lasted for three months, there was no need of any
procinetic drug. She had no nausea at all during this preg-
nancy. Just as after the first breast feeding, the vomiting
resumed three to four weeks after the breast feeding was
ceased. She did not make any changes in her dietary habits
during or after her pregnancies and breast feedings.
The activity of the endocrine system of the gut is enhanced
during pregnancy and lactation. Functionally, the effect of
this enhanced activity is to contend with conditions of
greater nutritional need by stepping up the digestive
capacity and rendering the metabolism anabolic. Several
of the peptides involved have been suggested to play a role
in the etiology of idiopathic gastroparesis [5]. As the
present patient was remarkably improved during preg-
nancy and breast feeding, the appropriate questions may
be, which changes during these conditions also restitute
impaired gastrointestinal motility, and which factors are
expressed in insufficient or increased concentrations
under normal conditions, leading to dysmotility.
The patient in question responded promptly to cisapride,
an agent that increases acetylcholine release by acting on
presynaptic serotonin (5-HT4) receptors [6]. This suggests
that serotonin and/or acetylcholine are important in this
dysfunction. However, it is not known whether either of
these neurotransmitters, both of which are of importance
for the stimulation of gastric motility [6,7], are expressed
in higher levels during pregnancy or breast feeding. The
ability to respond to therapy and pregnancy and breast
feeding argues against irreversible structural defects.
Several hormones of importance for gastrointestinal
motility are found at higher plasma concentrations during
pregnancy. One example is motilin, an important peptide
in digestive motility whose receptor is the site of action for
erythromycin in the treatment of gastroparesis [7]. Moti-
lin is elevated both during pregnancy and immediately
postpartum [8], whereas plasma concentrations during
breast feeding have to date not been examined. The moti-
lin-related peptide ghrelin, which originates primarily in
the stomach [9], has recently also been shown to enhance
gastric emptying in idiopathic gastroparesis [10]. How-
ever, this peptide is expressed at lower concentrations dur-
ing pregnancy than during normal conditions [11].
Other examples of hormones appearing in increased con-
centrations in the plasma during pregnancy are sex hor-
mones, which are known to delay gastrointestinal transit
time [12]. Furthermore, cholecystokinin (CCK) is ele-
vated during pregnancy and gastrin during breast feeding
[13,14]. These changes should rather impair gastric motil-
ity, as these hormones inhibit the gastric emptying during
physiological conditions [15].
Oxytocin, a hormone with well-known stimulatory effects
on myoepithelial cells and uterine smooth muscles, is ele-
vated during pregnancy and breast feeding [16,17].
Recently, oxytocin has been shown to be present through-
out the human gastrointestinal tract [18]. Furthermore, it
is released postprandially in healthy subjects [19]. When
the oxytocin receptor antagonist atosiban was adminis-
tered in conjunction with a meal, the gastric emptying rate
was prolonged [20]. Taken together, these findings indi-
cate that oxytocin may play a physiological role also in the
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Nitric oxide (NO) is one neurotransmitter assumed to be
of interest in the etiology of diabetic gastroparesis [21].
However, NO production has been shown to be unaf-
fected during pregnancy [22], suggesting that this is of
minor interest in the case under consideration. One may
further speculate about the altered profile of prostagland-
ins during pregnancy, but this has been only rudimentar-
ily examined [23].
Conclusion
Altogether, the hormonal and paracrine/autocrine
changes during pregnancy and breast feeding are complex,
and hormones with both stimulatory and inhibitory
effects on gastric emptying and motility are released in
higher amounts during these conditions. By studying
physiological processes during pregnancy and breast feed-
ing, we may learn more about the physiology and patho-
physiology of the gastrointestinal functions. Serotonin,
motilin and oxytocin may be of great interest, and devel-
opment of new agonists to these peptides calls for further
research.
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